NEW YORK (GenomeWeb News) — Quiatech, a developer of genetics-enabling technologies, has changed its name to Oligovation, the company said yesterday.
Oligovation said it has a modified RNA chemistry that improves synthesis conditions for RNA production, a specific reversible terminator for improving sequencing technology, and an in situ amplification technology for in vitro diagnostics.
The firm, based in Uppsala, Sweden, said it made the change as it prepares to market “a range of DNA and RNA technologies” it developed under the name Quiatech.